Structure-based classification of antibacterial activity.

The aim of this study was to develop a simple quantitative structure-activity relationship (QSAR) for the classification and prediction of antibacterial activity, so as to enable in silico screening. To this end a database of 661 compounds, classified according to whether they had antibacterial activity, and for which a total of 167 physicochemical and structural descriptors were calculated, was analyzed. To identify descriptors that allowed separation of the two classes (i.e. those compounds with and without antibacterial activity), analysis of variance was utilized and models were developed using linear discriminant and binary logistic regression analyses. Model predictivity was assessed and validated by the random removal of 30% of the compounds to form a test set, for which predictions were made from the model. The results of the analyses indicated that six descriptors, accounting for hydrophobicity and inter- and intramolecular hydrogen bonding, provided excellent separation of the data. Logistic regression analysis was shown to model the data slightly more accurately than discriminant analysis.

[1]  Mark T. D. Cronin,et al.  QSAR in Toxicology. 3. Prediction of Chronic Toxicities , 1995 .

[2]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[3]  A. Good,et al.  3-D pharmacophores in drug discovery. , 2001, Current pharmaceutical design.

[4]  A. Tropsha,et al.  Beware of q 2 , 2002 .

[5]  F. Tomás-Vert,et al.  Artificial neural network applied to the discrimination of antibacterial activity by topological methods , 2000 .

[6]  David Weininger,et al.  SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules , 1988, J. Chem. Inf. Comput. Sci..

[7]  S. Ekins,et al.  Progress in predicting human ADME parameters in silico. , 2000, Journal of pharmacological and toxicological methods.

[8]  E Uriarte,et al.  Recent advances on the role of topological indices in drug discovery research. , 2001, Current medicinal chemistry.

[9]  R. García-Domenech,et al.  Antimicrobial Activity Characterization in a Heterogeneous Group of Compounds. , 1998 .

[10]  A. Tropsha,et al.  Beware of q2! , 2002, Journal of molecular graphics & modelling.

[11]  J. Dearden,et al.  Partitioning and lipophilicity in quantitative structure-activity relationships. , 1985, Environmental health perspectives.

[12]  J. Mason,et al.  The design of combinatorial libraries using properties and 3D pharmacophore fingerprints. , 2001, Drug discovery today.

[13]  Ajay,et al.  Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? , 1998, Journal of medicinal chemistry.

[14]  M. Cronin,et al.  Pitfalls in QSAR , 2003 .

[15]  Rama K. Mishra,et al.  Getting Discriminant Functions of Antibacterial Activity from Physicochemical and Topological Parameters , 2001, J. Chem. Inf. Comput. Sci..

[16]  J. V. Julián-Ortiz,et al.  Virtual darwinian drug design: QSAR inverse problem, virtual combinatorial chemistry, and computational screening. , 2001 .

[17]  A. D. Russell,et al.  Antiseptics and Disinfectants: Activity, Action, and Resistance , 1999, Clinical Microbiology Reviews.

[18]  Tudor I. Oprea,et al.  Property distribution of drug-related chemical databases* , 2000, J. Comput. Aided Mol. Des..

[19]  J. Wölcke,et al.  Miniaturized HTS technologies - uHTS. , 2001, Drug discovery today.

[20]  T. Langer,et al.  Virtual screening: an effective tool for lead structure discovery? , 2001, Current pharmaceutical design.

[21]  Y. Kurogi,et al.  Pharmacophore modeling and three-dimensional database searching for drug design using catalyst. , 2001, Current medicinal chemistry.

[22]  Mark T. D. Cronin,et al.  The use of discriminant analysis, logistic regression and classification tree analysis in the development of classification models for human health effects , 2003 .

[23]  T W Schultz,et al.  Development of quantitative structure-activity relationships for the toxicity of aromatic compounds to Tetrahymena pyriformis: comparative assessment of the methodologies. , 2001, Chemical research in toxicology.

[24]  Ernesto Estrada,et al.  A novel approach for the virtual screening and rational design of anticancer compounds. , 2000, Journal of medicinal chemistry.

[25]  Wendy A. Warr.  Combinatorial Chemistry and Molecular Diversity. An Overview , 1997 .

[26]  Ajay,et al.  Designing libraries with CNS activity. , 1999, Journal of medicinal chemistry.

[27]  A Tropsha,et al.  Identification of the descriptor pharmacophores using variable selection QSAR: applications to database mining. , 2001, Current pharmaceutical design.

[28]  H. Kubinyi,et al.  A scoring scheme for discriminating between drugs and nondrugs. , 1998, Journal of medicinal chemistry.